Wall Street Zen Initiates Coverage on Streamline Health Solutions (NASDAQ:STRM)

Equities researchers at Wall Street Zen started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report released on Wednesday. The brokerage set a “sell” rating on the stock.

Streamline Health Solutions Stock Performance

Shares of NASDAQ:STRM opened at $2.18 on Wednesday. The company has a market capitalization of $9.32 million, a price-to-earnings ratio of -0.90 and a beta of 1.78. The firm’s 50 day simple moving average is $2.61 and its 200 day simple moving average is $3.14. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.46 and a quick ratio of 0.46. Streamline Health Solutions has a fifty-two week low of $1.82 and a fifty-two week high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last posted its earnings results on Thursday, May 1st. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.10). Streamline Health Solutions had a negative return on equity of 56.96% and a negative net margin of 50.51%. The business had revenue of $4.70 million for the quarter, compared to the consensus estimate of $4.70 million.

Hedge Funds Weigh In On Streamline Health Solutions

An institutional investor recently raised its position in Streamline Health Solutions stock. Nicholas Hoffman & Company LLC. increased its stake in Streamline Health Solutions, Inc. (NASDAQ:STRM) by 8.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,299 shares of the company’s stock after buying an additional 4,166 shares during the quarter. Nicholas Hoffman & Company LLC. owned approximately 1.22% of Streamline Health Solutions worth $146,000 as of its most recent SEC filing. Institutional investors own 31.74% of the company’s stock.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.